How A Drugmaker Gamed The System to Keep Generic Competition Away
Celgene Corp. has thwarted rival drugmakers eager to make cheaper versions of medicines for a form of blood cancer. Now administration officials are criticizing practices they say hold generics back.
Read more on NPR
Health Care
May 17, 2018 at 04:00PM
Blog Beauty 24/7
Không có nhận xét nào:
Đăng nhận xét